Mutated ATRX gene linked to brain tumors potential biomarker for rare adrenal tumors too

For the first time, researchers at Penn’s Abramson Cancer Center have found that a mutation in the ATRX may serve as a much-needed biomarker for the pheochromocytomas and paragangliomas that become malignant. These rare neuroendocrine tumors are typically benign, but when they go rogue, they become very aggressive. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *